Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Peterson Katharine sold 107 Acrivon Therapeutics, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Peterson Katharine (Chief Accounting Officer) sold 107 Acrivon Therapeutics, Inc. shares at US$1.45 for US$155, leaving 17,926 shares. Filed Nov 19, 2026 (Form 4).

Sold
107 shares
Price
US$1.45
Value
US$155
Holding after
17,926 shares
Trading plan
No
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockSale107US$1.4517,926Direct

Source

Download original · View original at SEC

Related